Such evidence, however, is supported by many relevant pre-clinical or mechanistic studies highlighting the neuroprotective and anti-inflammatory activity of these medications
Connect with a qualified healthcare practitioner to learn more
Patients ready to discuss their options can contact Maryland Trim Clinic to ask about a medical weight-loss evaluation and current treatment availability
STEP-1: Semaglutide 2,4 mg, the standard since 2021 The STEP-1 trial (Wilding et al., NEJM 2021, PMID 33567185) randomized 1,961 overweight or obese adults (BMI 30 or BMI 27 with comorbidities) without diabetes to semaglutide 2,4 mg/week or placebo, with lifestyle interventions administered concurrently in both arms
At Noor Medical Spa, we provide a comprehensive approach to Semaglutide GLP-1 treatment , ensuring safety, efficacy, and personalized care for weight management
Regular weekly doses are necessary for the treatment to work